The fair value estimate for Advanced Enzyme Technologies is held at ₹370, with analysts choosing not to shift their valuation anchor despite refreshed model inputs. That steady price target lines up ...

Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Industrial Enzymes - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Industrial Enzymes market is ...

CV5 Capital, the leading institutional platform for digital asset and tokenized fund launches, today announced a strategic partnership with Enzyme, the global infrastructure for tokenized finance.